South San Francisco, CA, United States of America

Leah Cleary

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.4

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Leah Cleary: Innovator in Pharmaceutical Compounds

Introduction

Leah Cleary is a prominent inventor based in South San Francisco, CA, known for her significant contributions to the field of pharmaceutical compounds. With a total of four patents to her name, she has made strides in developing innovative treatments for various diseases.

Latest Patents

Among her latest patents, Leah has developed dihydrothieno[3,2-b]pyridine compounds. These compounds are designed to have utility in the treatment of diseases, either alone or in combination with other agents. Additionally, she has worked on 2-oxoquinazoline derivatives that serve as methionine adenosyltransferase 2A inhibitors. These derivatives are crucial in creating pharmaceutical compositions aimed at treating diseases such as cancer, particularly those characterized by reduced or absent methylthioadenosine phosphorylase (MTAP) activity.

Career Highlights

Leah has had a notable career, working with companies such as Ideaya Biosciences, Inc. and Ideaya Bioscience, Inc. Her work has been instrumental in advancing the understanding and treatment of complex diseases through innovative pharmaceutical solutions.

Collaborations

Throughout her career, Leah has collaborated with talented individuals, including Muzaffar Alam and Melissa Fleury. These partnerships have contributed to her success and the development of her patented compounds.

Conclusion

Leah Cleary's work in the field of pharmaceutical innovations showcases her dedication to improving healthcare through her inventive spirit. Her contributions continue to pave the way for new treatments and advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…